Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
(NASDAQ:MBRX), – Live video webcast on Wednesday, August 20th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it will present at the Webull Financial […]